| HOME >> MEDICINE >> TECHNOLOGY |
822,227
273,975Prepaid expenses and other current assets from affiliated entity
992,245
653,436Total current assets38,606,721
22,877,207Fixed assets, net
306,113
276,795Intangible assets, net
10,239,436
11,180,002Goodwill
10,113,371
10,113,371Investment in affiliated entity
8,383,650
11,360,888Other assets
208,262
259,128Total assets$ 67,857,553
$ 56,067,391LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable and accrued expenses
$ 3,242,943
$ 3,410,610Accounts payable and accrued expenses due to affiliated entity
757,489
1,680,947Accrued clinical trial expenses426,471
178,328Common stock warrants
4,867,672
370,926Deferred revenue
233,161
420,897Deferred revenue from affiliated entity
413,542
375,000Total current liabilities9,941,278
6,436,708Deferred revenue, net of current portion
66,644
72,780Deferred revenue from affiliated entity, net of current portion2,149,194
2,336,694Deferred rent, net of current portion
66,154
67,112Deferred tax liabilities
53,186
53,186Total liabilities12,276,456
8,966,480Stockholders' equity:Inovio Pharmaceuticals, Inc. stockholders' equity:Common stock
127,257
105,038Additional paid-in capital
254,956,417
241,233,334Accumulated deficit(200,073,001)
(194,838,229)Accumulated other comprehensive income
(2,941)
2,850Total Inovio Pharmaceuticals, Inc. stockholders' equity55,007,732
46,502,993Non-controlling interest
573,365
597,918Total stockholders' equity
55,581,097
47,100,911Total liabilities and stockholders' equity$ 67,857,553
$ 56,067,391INOVIO PHARMACEUTICALS, INCCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited)Three
'/>"/>
| SOURCE Inovio Pharmaceuticals, Inc. Copyright©2010 PR Newswire. All rights reserved |